Smoking's Impact on Vascular Health

Pathophysiological Mechanisms

Smoking affects vascular biology through multiple pathways, including endothelial dysfunction, oxidative stress, and inflammation, as noted by the European Society of Cardiology 1

Smoking cessation is the most cost-effective strategy for cardiovascular disease prevention and may help improve vascular-related skin manifestations, according to the European Society of Cardiology 1, 2
Stopping smoking can lead to significant morbidity reductions within the first 6 months, with risk of cardiovascular disease approaching the risk of never-smokers within 10-15 years, as reported by the European Society of Cardiology 3

Patients with palmar telangiectasias or erythema should be informed about the association with smoking and advised to quit, as recommended by the American Academy of Dermatology 4
Healthcare providers should offer assistance with smoking cessation through follow-up support, nicotine replacement therapies, varenicline, and bupropion individually or in combination, as suggested by the European Society of Cardiology 1 and the American Academy of Dermatology 4
Patients should be counseled that smoking cessation may lead to gradual improvement in vascular-related skin manifestations, though complete resolution may not occur, as noted by the European Society of Cardiology 3 and the American Academy of Dermatology 4

The dose-response relationship between smoking and vascular manifestations means that even low levels of smoking can contribute to these findings, as reported by the European Society of Cardiology 1, 3
Passive smoking also increases cardiovascular risk and may contribute to vascular changes, so complete avoidance of smoke exposure is recommended, according to the European Society of Cardiology 2